View Full Paper

Owner Consent Verified
Research Proposal 4.8

Governance And Risk in Supply Chain Resilience for Pharmaceutical Firms: A Comparative Perspective

37
Pages
Harvard
Style
~ 39–55 mins
Reading Time
Public Policy AR/VR FinTech
Abstract

This research proposal investigates “Governance And Risk in Supply Chain Resilience for Pharmaceutical Firms: A Comparative Perspective” using a qualitative grounded theory. Through a economic lens, the analysis integrates multi-source data to derive a practical decision framework for researchers and practitioners.

Governance And Risk in Supply Chain Resilience for Pharmaceutical Firms: A Comparative Perspective

ABSTRACT
Governance And Risk in Supply Chain Resilience for Pharmaceutical Firms: A Comparative Perspective is unpacked across themes: costs, benefits, change enablement, and ethics. Limitations and future research paths are noted.
1
Related Papers
Browse all
35 Pages 4.6
Ethical AI Adoption in Hospital Administrators: Resilience And Continuity — A qualitative grounded theory
Telemedicine CV Marketing
5 Pages 4.2
Blockchain and Operational Excellence among Hospital Administrators — 2024–2029 Trends
RPA NLP Epidemiology
8 Pages 4.3
Hydrogen Economy for Export-Oriented Manufacturers: Adoption Barriers | 2022–2027 Trends
Governance CV Finance